6533b82cfe1ef96bd128f609
RESEARCH PRODUCT
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use
Manuela MarzoVito AnneseMichele ComberlatoTommaso StefanelliSilvio DaneseElisabetta ColomboAlberto MalesciAlessandro ArmuzziAldo MancaLuisa GuidiMario CottoneMarcello VangeliCosimo PranteraRaffaella PulitanòMaria Lia ScribanoFilippo Mocciarosubject
medicine.medical_specialtyCrohn's diseasetherapybusiness.industryGastroenterologyCompassionate Usemedicine.diseaseCertolizumabInfliximabClinical trialPharmacotherapyRefractoryCertolizumab Crohn's disease RefractoryInternal medicinemedicineImmunology and AllergyCertolizumab pegolbusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2008-08-01 |